دورية أكاديمية
أعرض في EDS

Holmium laser enucleation of the prostate (HoLEP) in short-circuit outpatient care: Is prostatic volume a limiting factor?

التفاصيل البيبلوغرافية
العنوان: Holmium laser enucleation of the prostate (HoLEP) in short-circuit outpatient care: Is prostatic volume a limiting factor?
المؤلفون: Maria SR; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Franco M; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Freixa Sala R; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Gasanz Serrano C; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Bernardello Ureta M; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Bultó Gonzalvo R; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Cervera Alcaide J; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Casanova García C; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., García Puche M; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Segura Alabart M; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Areal Calama JJ; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain., Ágreda Castañeda F; Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain.
المصدر: Lower urinary tract symptoms [Low Urin Tract Symptoms] 2024 Jul; Vol. 16 (4), pp. e12525.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: Richmond, Vic. Country of Publication: Australia NLM ID: 101506777 Publication Model: Print Cited Medium: Internet ISSN: 1757-5672 (Electronic) Linking ISSN: 17575664 NLM ISO Abbreviation: Low Urin Tract Symptoms Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Richmond, Vic. : Blackwell Publishing Asia, 2009-
مواضيع طبية MeSH: Lasers, Solid-State*/therapeutic use , Prostatic Hyperplasia*/surgery , Prostate*/surgery , Ambulatory Care*/methods, Humans ; Male ; Aged ; Organ Size ; Middle Aged ; Length of Stay ; Prostatectomy/methods ; Prostatectomy/adverse effects ; Treatment Outcome ; Laser Therapy/methods ; Ambulatory Surgical Procedures/methods
مستخلص: Introduction and Objectives: Our goals were to study prostatic volume as a limiting factor after HoLEP surgery with short-circuit outpatient care (4 h) and to define other factors that affect the success of the proposed circuit.
Materials and Methods: An observational analysis and review was performed using a prospective database. Preoperative, intraoperative, and postoperative variables were included for patients who were scheduled for short-circuit outpatient care (SCOC) and who underwent HoLEP between 2020 and 2023. We defined SCOC as a postoperative hospital stay of 4 h. Subjects who required more than 4 h in hospital were categorized as conventional hospital admission (CHA). A descriptive populational study was conducted, expressing the mean using a 95% confidence interval and percentages for the continuous variables. In order to analyze them, we used the Student's t-test for the continuous variables and the chi-squared test for the categorical variables.
Results: Sixty-eight patients were included, 54 of which completed SCOC, which represented a success ratio of 79.5%. The mean age and prostatic volume of the whole cohort were 68.9 (±6.8) years and 79.5 (±29.1) mL, respectively. We found no significant differences in age, prostatic volume, antiplatelet drug use, indwelling bladder catheter, or applied energy among the subjects who completed SCOC and those who required CHA. No patient was presented with a complication of Grade 3 (or higher) in the modified Clavien-Dindo classification. At the six-month follow-up, no differences were observed in the uroflowmetry or International Prostate Symptoms Score variables.
Conclusions: Prostatic volume does not seem to be a limiting factor after undergoing HoLEP with short-circuit outpatient care.
(© 2024 John Wiley & Sons Australia, Ltd.)
References: Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow‐up of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64:118‐140.
DeCao H, Wang J, Huang Y, et al. Comparison between thulium laser resection of prostate and transurethral plasmakinetic resection of prostate or transurethral resection of prostate. Sci Rep. 2015;5:14542.
Xu H, Wan X, Gu M, et al. Surgical treatment for benign prostatic hyperplasia: holmium laser enucleation of the prostate (HoLEP). J Vis Exp. 2018;133:56683. doi:10.3791/56683.
Ahyai SA, Gilling P, Kaplan SA, et al. Meta‐analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58:384‐397.
Sun F, Sun X, Shi Q, Zhai Y. Transurethral procedures in the treatment of benign prostatic hyperplasia: a systematic review and meta‐analysis of effectiveness and complications. Medicine (Baltimore). 2018;97:e13360.
Parsons JK, Dahm P, Köhler TS, Lerner LB, Wilt TJ. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol. 2020;204:799‐804.
Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180:246‐249.
Larner TRG, Agarwal D, Costello AJ. Day‐case holmium laser enucleation of the prostate for gland volumes of <60 mL: early experience. BJU Int. 2003;91:61‐64.
Jumper C, Snyder P, Yap RL. Rapid ambulatory pathway laser prostatectomy is safe: results within the global period. BJU Int. 2012;110:1190‐1193.
Cynk M, Georgiadis G, Moore E, Appleby J, Griffiths R, Hale J. Day‐case holmium laser enucleation of the prostate. J Clin Urol. 2015;8:268‐273.
Comat V, Marquette T, Sutter W, et al. Day‐case holmium laser enucleation of the prostate: prospective evaluation of 90 consecutive cases. J Endourol. 2017;31:1056‐1061.
Lee S‐M, Gordon K, McMillan R, Crystal F, Acher P. Day‐case holmium laser enucleation of the prostate: feasibility, safety and predictive factors. Ann R Coll Surg Engl. 2018;100:475‐479.
Abdul‐Muhsin H, Critchlow W, Navaratnam A, et al. Feasibility of holmium laser enucleation of the prostate as a 1‐day surgery. World J Urol. 2020;38:1017‐1025.
Lwin AA, Zeng J, Evans P, et al. Holmium laser enucleation of the prostate is safe and feasible as a same day surgery. Urology. 2020;138:119‐124.
Klein C, Marquette T, Comat V, et al. Evolution of day‐case holmium laser enucleation of the prostate success rate over time. J Endourol. 2021;35:342‐348.
Blanco Fernández R, González Rodríguez I, Fernández‐Pello Montes S, et al. Holmium laser enucleation of the prostate (HoLEP) as same‐day surgery: a safe and feasible option. Actas Urol Esp Engl Ed. 2023;47:457‐461.
Agreda Castañeda F, Buisan Rueda Ó, Areal Calama JJ. Análisis de las complicaciones en el aprendizaje del HoLEP: revisión sistemática. Actas Urol Esp. 2020;44:1‐8.
فهرسة مساهمة: Keywords: HoLEP; benign prostatic hyperplasia; outcome assessment; outpatient care
تواريخ الأحداث: Date Created: 20240716 Date Completed: 20240716 Latest Revision: 20240717
رمز التحديث: 20240718
DOI: 10.1111/luts.12525
PMID: 39011566
قاعدة البيانات: MEDLINE
الوصف
تدمد:1757-5672
DOI:10.1111/luts.12525